Tumour microenvironment diversity of HNSCC and the molecular landscape of recurrent disease.

By K. Steele, Catherine Barnett, R. Ladwa, Meg L. Donovan, Clara Lawler, A. Kulasinghe. 2026

Subfields: Oncology, Otorhinolaryngology

Citations in the corpus

• TROP2 expression in head and neck squamous cell carcinoma: association with the tumor immune microenvironment and clinical outcome (2026, unknown): “HNSCC is characterized by a highly heterogeneous immune landscape, with tumor-in fi ltrating lymphocytes, regulatory T cells, and macrophage subsets contributing to immune evasion and therapeutic response (20 – 22).”